Predictmedix Inc
CNSX:PMED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Predictmedix Inc
CNSX:PMED
|
CA |
|
A
|
A2 Milk Company Ltd
SWB:14L
|
NZ |
|
SWCC Showa Holdings Co Ltd
TSE:5805
|
JP |
|
Weihai Guangtai Airport Equipment Co Ltd
SZSE:002111
|
CN |
|
American Tower Corp
NYSE:AMT
|
US |
|
Luye Pharma Group Ltd
HKEX:2186
|
CN |
|
Glosel Co Ltd
TSE:9995
|
JP |
|
G
|
Global Battery Metals Ltd
OTC:REZZF
|
CA |
Balance Sheet
Balance Sheet Decomposition
Predictmedix Inc
Predictmedix Inc
Balance Sheet
Predictmedix Inc
| Jul-2006 | Jul-2007 | Jul-2008 | Jul-2009 | Jul-2010 | Jan-2019 | Jan-2020 | Jan-2021 | Jan-2022 | Jan-2023 | Jan-2024 | Jan-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
1
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
1
|
4
|
1
|
0
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
|
| PP&E Net |
37
|
44
|
61
|
72
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
37
|
44
|
61
|
72
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
1
|
3
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
2
|
2
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
40
N/A
|
47
+18%
|
64
+38%
|
74
+15%
|
2
-97%
|
2
-26%
|
2
-4%
|
1
-40%
|
1
+23%
|
1
-42%
|
0
-33%
|
0
-73%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
5
|
3
|
0
|
3
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
2
|
5
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
5
|
5
|
9
|
13
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Long-Term Debt |
5
|
16
|
33
|
43
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
11
N/A
|
22
+107%
|
44
+99%
|
58
+33%
|
1
-98%
|
0
-100%
|
0
+488%
|
0
+577%
|
0
+158%
|
1
+149%
|
1
-28%
|
1
+132%
|
|
| Equity | |||||||||||||
| Common Stock |
39
|
40
|
52
|
58
|
58
|
2
|
4
|
4
|
6
|
6
|
7
|
7
|
|
| Retained Earnings |
20
|
26
|
45
|
57
|
72
|
0
|
2
|
4
|
6
|
7
|
9
|
10
|
|
| Additional Paid In Capital |
11
|
11
|
15
|
16
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
29
N/A
|
25
-15%
|
21
-16%
|
16
-23%
|
1
-93%
|
2
+50%
|
2
-5%
|
1
-47%
|
1
+2%
|
0
N/A
|
0
+6%
|
1
-818%
|
|
| Total Liabilities & Equity |
40
N/A
|
47
+18%
|
64
+38%
|
74
+15%
|
2
-97%
|
2
-26%
|
2
-4%
|
1
-40%
|
1
+23%
|
1
-42%
|
0
-33%
|
0
-73%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
4
|
4
|
4
|
5
|
5
|
93
|
104
|
102
|
109
|
122
|
150
|
150
|
|